These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury. Gentile NT; McIntosh TK Ann Emerg Med; 1993 Jun; 22(6):1028-34. PubMed ID: 8099259 [TBL] [Abstract][Full Text] [Related]
6. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. McIntosh TK; Juhler M; Wieloch T J Neurotrauma; 1998 Oct; 15(10):731-69. PubMed ID: 9814632 [TBL] [Abstract][Full Text] [Related]
7. Central nervous system resuscitation. McIntosh TK; Garde E; Saatman KE; Smith DH Emerg Med Clin North Am; 1997 Aug; 15(3):527-50. PubMed ID: 9255131 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment of central nervous system trauma. Faden AI Pharmacol Toxicol; 1996 Jan; 78(1):12-7. PubMed ID: 8685080 [TBL] [Abstract][Full Text] [Related]
9. [Anti-inflammatory modulators in traumatic brain injury]. Lescot T; Marchand-Verrecchia C; Puybasset L Ann Fr Anesth Reanim; 2006 Jul; 25(7):755-60. PubMed ID: 16675184 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for traumatic brain injury: a review. Raghupathi R; McIntosh TK Proc West Pharmacol Soc; 1998; 41():241-6. PubMed ID: 9836300 [TBL] [Abstract][Full Text] [Related]
11. The rationale for glutamate antagonists in the treatment of traumatic brain injury. Myseros JS; Bullock R Ann N Y Acad Sci; 1995 Sep; 765():262-71; discussion 298. PubMed ID: 7486612 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic therapy for traumatic brain injury: experimental approaches. Smith DH; Casey K; McIntosh TK New Horiz; 1995 Aug; 3(3):562-72. PubMed ID: 7496768 [TBL] [Abstract][Full Text] [Related]
13. Regulation of intracellular free magnesium in central nervous system injury. Vink R; Cernak I Front Biosci; 2000 Aug; 5():D656-65. PubMed ID: 10922299 [TBL] [Abstract][Full Text] [Related]
14. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Bernert H; Turski L Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559 [TBL] [Abstract][Full Text] [Related]
15. [Neurochemical changes and current pharmacological approaches in craniocerebral trauma]. Kossmann T; Lenzlinger PM; Stover JF; Stocker R; Morganti-Kossmann MC; Trentz O Unfallchirurg; 1997 Aug; 100(8):613-22. PubMed ID: 9381209 [TBL] [Abstract][Full Text] [Related]
16. Conceptual and practical issues in the pharmacological treatment of brain injury. Stein DG; Glasier MM; Hoffman SW J Neural Transplant Plast; 1993; 4(3):227-37. PubMed ID: 8018754 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical characterization of traumatic brain injury in humans. Regner A; Alves LB; Chemale I; Costa MS; Friedman G; Achaval M; Leal L; Emanuelli T J Neurotrauma; 2001 Aug; 18(8):783-92. PubMed ID: 11526984 [TBL] [Abstract][Full Text] [Related]
18. Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. Cater HL; Gitterman D; Davis SM; Benham CD; Morrison B; Sundstrom LE J Neurochem; 2007 Apr; 101(2):434-47. PubMed ID: 17250683 [TBL] [Abstract][Full Text] [Related]